Stocks Listing
ERGO.L

Ergomed plc

Share
ERGO.L
$1,583.73 0.7%Last Updated Sep 28 2022 02:57 PM
1D Low / 1D High
Low:$1,530.47
High:$1,603.35
1D
0.7%
5D
-
30D
-
BulletPurple
Market Cap
$791,071,467
0.7 %
791.1 M
BulletBlue
Volume 1D
120,050
-
120.1 K
BulletOrange
Circulating Supply
499,500 ERGO.L
499.5 K

Price Chart

1D
5D
1M
6M
YTD
1Y
MAX
About

Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, Rest of Europe, the Middle East, Africa, North America, Asia, and Australia. It operates through two segments, Clinical Research Outsourcing and Pharmacovigilance. The company provides and manages clinical development, post-approval management, and pharmacovigilance services for pharmaceutical and generics companies, as well as small and mid-sized drug development companies. It focuses on various therapeutic areas, including oncology, haematology, allergy, respiratory, and neurology/CNS, as well as develops orphan drugs. The company also provides site support services. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.

Historical data

1D
5D
1M
6M
1Y
MAX
Day
Open - Close
Low/High
Volume
Market Cap
Show More
Market Status
Closed
LSE
London Stock Exchange
GBR
Opens in
14 hours, 48 minutes
Working Hours
Mon-Fri, 07:00 AM - 11:00 AM / 11:02 AM - 03:30 PM
Timezone
GMT+0